Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001062993-24-005757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-06 | 2024-03-05 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $3.44 | -13.0K | 255.3K | -5% | -$44.6K |
| D | 2024-03-06 | 2024-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +133.0K | 261.3K | +104% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +199.5K | 199.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 6,975 | $3.44 | 248,290 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-05 | S | D | 6,016 | $3.43 | 255,265 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-04 | A | A | 132,979 | $0.00 | 261,281 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-03-04 | A | A | 199,549 | $0.00 | 199,549 | D | $3.99 · — to 2034-03-04 | 199,549 Common Stock | (F2) The options vest with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |